Evrofarma SA (ATH:EVROF)
3.410
+0.090 (2.71%)
At close: Mar 11, 2026
86.34% (1Y)
| Market Cap | 46.63M +70.5% |
| Revenue (ttm) | 45.72M -6.2% |
| Net Income | 2.28M +3.5% |
| EPS | n/a |
| Shares Out | 13.67M |
| PE Ratio | 21.33 |
| Forward PE | n/a |
| Dividend | 0.05 (1.51%) |
| Ex-Dividend Date | Aug 19, 2025 |
| Volume | 2,570 |
| Average Volume | 4,069 |
| Open | 3.320 |
| Previous Close | 3.320 |
| Day's Range | 3.280 - 3.430 |
| 52-Week Range | 1.605 - 4.070 |
| Beta | 0.73 |
| RSI | 38.32 |
| Earnings Date | Apr 9, 2026 |